Wednesday, May 19, 2010

DMT study

I just received an Email  from an MS Village contact requesting response from the Canadian MS Community who are currently taking Disease Modifying Treatments (*Specifically Rebif or Copaxone  for 1 to 6 years) for Multiple Sclerosis.  Please read and respond if you fit this criteria.




Hello,
I am sending this e-mail from MPI Research on behalf of the MS Village and we are inviting Canadians with multiple sclerosis who take the product Rebif or Copaxone to give their views on current and potential new treatments for MS.
Criteria for this study:
-          Must currently be taking Rebif treatment between 1 - 6 years presently.
-          Must currently be taking Copaxone treatment between 1 - 6 years presently.
This study is strictly a research project and your answers will be kept completely confidential.
 A monetary honorarium will be provided to qualified respondents who complete the survey.
 This survey will take approximately 30 minutes to complete, and will be:
·       Conducted by telephone at a time convenient to you
 If you would be interested in participating, please contact me toll free at 1-866-332-6696 so that I may ask you a few questions to see if this study is of interest to you.
 We are seeking participants asap. Therefore, you can reach me directly between 9:30AM-5:30PM (Eastern Standard Time) Mondays through Fridays.
Sincerely,
Chris Kyte
1-866-332-6696
Chris Kyte
Research Associate
MPI Research
181 Hymus Boulevard, Suite 202
Pointe-Claire, Québec H9R 1E9

No comments:

Post a Comment

Back home

Begin the adventure: The trip there was uneventful. Not really boring it started out with a trip from home to the Airport.  Thanks to the...